Cargando…
Clinical performance testing of the automated haematology analyzer XN-31 prototype using whole blood samples from patients with imported malaria in Japan
BACKGROUND: The automated haematology analyzer XN-31 prototype (XN-31p) is a new flow cytometry-based device developed to measure the number and the ratio of malaria-infected red blood cells (MI-RBC) with a complete blood count (CBC). The XN-31p can provide results in about one minute and also can s...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9338637/ https://www.ncbi.nlm.nih.gov/pubmed/35907857 http://dx.doi.org/10.1186/s12936-022-04247-x |
_version_ | 1784760014431322112 |
---|---|
author | Komaki-Yasuda, Kanako Kutsuna, Satoshi Kawaguchi, Miki Kamei, Mina Uchihashi, Kinya Nakamura, Keiji Nakamoto, Takato Ohmagari, Norio Kano, Shigeyuki |
author_facet | Komaki-Yasuda, Kanako Kutsuna, Satoshi Kawaguchi, Miki Kamei, Mina Uchihashi, Kinya Nakamura, Keiji Nakamoto, Takato Ohmagari, Norio Kano, Shigeyuki |
author_sort | Komaki-Yasuda, Kanako |
collection | PubMed |
description | BACKGROUND: The automated haematology analyzer XN-31 prototype (XN-31p) is a new flow cytometry-based device developed to measure the number and the ratio of malaria-infected red blood cells (MI-RBC) with a complete blood count (CBC). The XN-31p can provide results in about one minute and also can simultaneously provide information on the malaria parasite (Plasmodium) species. In this study, clinical testing of the XN-31p was performed using blood samples from patients with imported malaria in Japan. METHODS: Blood samples were collected from 80 patients who visited the hospital of the National Center for Global Health and Medicine, Tokyo, Japan, for malaria diagnosis from January 2017 to January 2019. The test results by the XN-31p were compared with those by other standard methods, such as microscopic observation, rapid diagnostic tests and the nested PCR. RESULTS: Thirty-three patients were diagnosed by the nested PCR as being malaria positive (28 Plasmodium falciparum, 2 Plasmodium vivax, 1 Plasmodium knowlesi, 1 mixed infection of P. falciparum and Plasmodium malariae, and 1 mixed infection of P. falciparum and Plasmodium ovale), and the other 47 were negative. The XN-31p detected 32 patients as “MI-RBC positive”, which almost matched the results by the nested PCR and, in fact, completely matched with the microscopic observations. The ratio of RBCs infected with malaria parasites as determined by the XN-31p showed a high correlation coefficient of more than 0.99 with the parasitaemia counted under microscopic observation. The XN-31p can analyse the size and nucleic acid contents of each cell, and the results were visualized on a two-dimensional cytogram termed the “M scattergram”. Information on species and developmental stages of the parasites could also be predicted from the patterns visualized in the M scattergrams. The XN-31p showed a positive coincidence rate of 0.848 with the nested PCR in discriminating P. falciparum from the other species. CONCLUSIONS: The XN-31p could rapidly provide instructive information on the ratio of MI-RBC and the infecting Plasmodium species. It was regarded to be of great help for the clinical diagnosis of malaria. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12936-022-04247-x. |
format | Online Article Text |
id | pubmed-9338637 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-93386372022-07-31 Clinical performance testing of the automated haematology analyzer XN-31 prototype using whole blood samples from patients with imported malaria in Japan Komaki-Yasuda, Kanako Kutsuna, Satoshi Kawaguchi, Miki Kamei, Mina Uchihashi, Kinya Nakamura, Keiji Nakamoto, Takato Ohmagari, Norio Kano, Shigeyuki Malar J Methodology BACKGROUND: The automated haematology analyzer XN-31 prototype (XN-31p) is a new flow cytometry-based device developed to measure the number and the ratio of malaria-infected red blood cells (MI-RBC) with a complete blood count (CBC). The XN-31p can provide results in about one minute and also can simultaneously provide information on the malaria parasite (Plasmodium) species. In this study, clinical testing of the XN-31p was performed using blood samples from patients with imported malaria in Japan. METHODS: Blood samples were collected from 80 patients who visited the hospital of the National Center for Global Health and Medicine, Tokyo, Japan, for malaria diagnosis from January 2017 to January 2019. The test results by the XN-31p were compared with those by other standard methods, such as microscopic observation, rapid diagnostic tests and the nested PCR. RESULTS: Thirty-three patients were diagnosed by the nested PCR as being malaria positive (28 Plasmodium falciparum, 2 Plasmodium vivax, 1 Plasmodium knowlesi, 1 mixed infection of P. falciparum and Plasmodium malariae, and 1 mixed infection of P. falciparum and Plasmodium ovale), and the other 47 were negative. The XN-31p detected 32 patients as “MI-RBC positive”, which almost matched the results by the nested PCR and, in fact, completely matched with the microscopic observations. The ratio of RBCs infected with malaria parasites as determined by the XN-31p showed a high correlation coefficient of more than 0.99 with the parasitaemia counted under microscopic observation. The XN-31p can analyse the size and nucleic acid contents of each cell, and the results were visualized on a two-dimensional cytogram termed the “M scattergram”. Information on species and developmental stages of the parasites could also be predicted from the patterns visualized in the M scattergrams. The XN-31p showed a positive coincidence rate of 0.848 with the nested PCR in discriminating P. falciparum from the other species. CONCLUSIONS: The XN-31p could rapidly provide instructive information on the ratio of MI-RBC and the infecting Plasmodium species. It was regarded to be of great help for the clinical diagnosis of malaria. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12936-022-04247-x. BioMed Central 2022-07-30 /pmc/articles/PMC9338637/ /pubmed/35907857 http://dx.doi.org/10.1186/s12936-022-04247-x Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Methodology Komaki-Yasuda, Kanako Kutsuna, Satoshi Kawaguchi, Miki Kamei, Mina Uchihashi, Kinya Nakamura, Keiji Nakamoto, Takato Ohmagari, Norio Kano, Shigeyuki Clinical performance testing of the automated haematology analyzer XN-31 prototype using whole blood samples from patients with imported malaria in Japan |
title | Clinical performance testing of the automated haematology analyzer XN-31 prototype using whole blood samples from patients with imported malaria in Japan |
title_full | Clinical performance testing of the automated haematology analyzer XN-31 prototype using whole blood samples from patients with imported malaria in Japan |
title_fullStr | Clinical performance testing of the automated haematology analyzer XN-31 prototype using whole blood samples from patients with imported malaria in Japan |
title_full_unstemmed | Clinical performance testing of the automated haematology analyzer XN-31 prototype using whole blood samples from patients with imported malaria in Japan |
title_short | Clinical performance testing of the automated haematology analyzer XN-31 prototype using whole blood samples from patients with imported malaria in Japan |
title_sort | clinical performance testing of the automated haematology analyzer xn-31 prototype using whole blood samples from patients with imported malaria in japan |
topic | Methodology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9338637/ https://www.ncbi.nlm.nih.gov/pubmed/35907857 http://dx.doi.org/10.1186/s12936-022-04247-x |
work_keys_str_mv | AT komakiyasudakanako clinicalperformancetestingoftheautomatedhaematologyanalyzerxn31prototypeusingwholebloodsamplesfrompatientswithimportedmalariainjapan AT kutsunasatoshi clinicalperformancetestingoftheautomatedhaematologyanalyzerxn31prototypeusingwholebloodsamplesfrompatientswithimportedmalariainjapan AT kawaguchimiki clinicalperformancetestingoftheautomatedhaematologyanalyzerxn31prototypeusingwholebloodsamplesfrompatientswithimportedmalariainjapan AT kameimina clinicalperformancetestingoftheautomatedhaematologyanalyzerxn31prototypeusingwholebloodsamplesfrompatientswithimportedmalariainjapan AT uchihashikinya clinicalperformancetestingoftheautomatedhaematologyanalyzerxn31prototypeusingwholebloodsamplesfrompatientswithimportedmalariainjapan AT nakamurakeiji clinicalperformancetestingoftheautomatedhaematologyanalyzerxn31prototypeusingwholebloodsamplesfrompatientswithimportedmalariainjapan AT nakamototakato clinicalperformancetestingoftheautomatedhaematologyanalyzerxn31prototypeusingwholebloodsamplesfrompatientswithimportedmalariainjapan AT ohmagarinorio clinicalperformancetestingoftheautomatedhaematologyanalyzerxn31prototypeusingwholebloodsamplesfrompatientswithimportedmalariainjapan AT kanoshigeyuki clinicalperformancetestingoftheautomatedhaematologyanalyzerxn31prototypeusingwholebloodsamplesfrompatientswithimportedmalariainjapan |